Welltower (NYSE:WELL) PT Raised to $105.00 at Mizuho

Welltower (NYSE:WELLGet Free Report) had its price target raised by stock analysts at Mizuho from $98.00 to $105.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the real estate investment trust’s stock. Mizuho’s price target points to a potential upside of 5.89% from the stock’s previous close.

A number of other equities research analysts also recently weighed in on WELL. Deutsche Bank Aktiengesellschaft started coverage on shares of Welltower in a research note on Tuesday, January 30th. They set a “buy” rating and a $115.00 price target on the stock. Scotiabank decreased their target price on shares of Welltower from $97.00 to $96.00 and set a “sector outperform” rating on the stock in a research report on Monday, March 4th. BNP Paribas began coverage on shares of Welltower in a research note on Monday, March 18th. They issued an “outperform” rating and a $104.00 target price on the stock. Finally, StockNews.com upgraded shares of Welltower from a “sell” rating to a “hold” rating in a research note on Monday. Five analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $96.07.

View Our Latest Analysis on Welltower

Welltower Stock Up 0.8 %

WELL stock opened at $99.16 on Wednesday. Welltower has a twelve month low of $72.47 and a twelve month high of $99.34. The company has a quick ratio of 3.83, a current ratio of 3.83 and a debt-to-equity ratio of 0.50. The company has a market cap of $59.29 billion, a PE ratio of 122.42, a price-to-earnings-growth ratio of 2.42 and a beta of 1.07. The business’s 50-day simple moving average is $92.60 and its 200 day simple moving average is $90.06.

Welltower (NYSE:WELLGet Free Report) last announced its quarterly earnings data on Monday, April 29th. The real estate investment trust reported $0.22 EPS for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.72). Welltower had a return on equity of 1.77% and a net margin of 6.37%. The firm had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter in the prior year, the business posted $0.85 EPS. Welltower’s revenue was up 19.2% compared to the same quarter last year. On average, research analysts anticipate that Welltower will post 4.06 earnings per share for the current year.

Hedge Funds Weigh In On Welltower

Institutional investors and hedge funds have recently bought and sold shares of the business. Bruce G. Allen Investments LLC bought a new position in shares of Welltower in the fourth quarter valued at about $25,000. Rise Advisors LLC bought a new position in shares of Welltower in the first quarter worth about $27,000. Headlands Technologies LLC grew its stake in shares of Welltower by 479.6% during the third quarter. Headlands Technologies LLC now owns 313 shares of the real estate investment trust’s stock valued at $26,000 after purchasing an additional 259 shares during the last quarter. Manchester Capital Management LLC increased its holdings in shares of Welltower by 338.7% in the first quarter. Manchester Capital Management LLC now owns 329 shares of the real estate investment trust’s stock valued at $31,000 after purchasing an additional 254 shares in the last quarter. Finally, Scarborough Advisors LLC bought a new position in Welltower in the 4th quarter worth approximately $35,000. Institutional investors and hedge funds own 94.80% of the company’s stock.

About Welltower

(Get Free Report)

Welltower Inc (NYSE:WELL), a REIT and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

Featured Stories

Analyst Recommendations for Welltower (NYSE:WELL)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.